Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: Is radiotherapy necessary after D2-dissection?

doi:10.3748/wjg.v20.i36.12900

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 36

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8448)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

450

WORD

322

HTML

4750

Figures (1-2)

338

Tables (1-3)

241

Sum=6101

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1163

Download

1184

Sum=2347

Sep 28, 2014 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Sep 28, 2014; 20(36): 12900-12907
Published online Sep 28, 2014. doi: 10.3748/wjg.v20.i36.12900

Full Size Figure Download Figure

Figure 1 Treatment and randomization schemes of the SWOG/INT-0116 and ARTIST trials. 5-FU: 5-fluorouracil.

Citation: Chang JS, Koom WS, Lee Y, Yoon HI, Lee HS. Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: Is radiotherapy necessary after D2-dissection? World J Gastroenterol 2014; 20(36): 12900-12907
URL: https://www.wjgnet.com/1007-9327/full/v20/i36/12900.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i36.12900